GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » EV-to-FCF

Paxman AB (FRA:B0F) EV-to-FCF : 46.07 (As of May. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Paxman AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Paxman AB's Enterprise Value is €62.75 Mil. Paxman AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was €1.36 Mil. Therefore, Paxman AB's EV-to-FCF for today is 46.07.

The historical rank and industry rank for Paxman AB's EV-to-FCF or its related term are showing as below:

FRA:B0F' s EV-to-FCF Range Over the Past 10 Years
Min: -353.06   Med: 92.24   Max: 1820.27
Current: 46.95

During the past 7 years, the highest EV-to-FCF of Paxman AB was 1820.27. The lowest was -353.06. And the median was 92.24.

FRA:B0F's EV-to-FCF is ranked worse than
68.33% of 360 companies
in the Medical Devices & Instruments industry
Industry Median: 28.725 vs FRA:B0F: 46.95

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Paxman AB's stock price is €3.20. Paxman AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.037. Therefore, Paxman AB's PE Ratio for today is 86.49.


Paxman AB EV-to-FCF Historical Data

The historical data trend for Paxman AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB EV-to-FCF Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -56.53 -30.49 -42.26 -24.19 -70.98

Paxman AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.19 151.99 123.68 79.40 -70.98

Competitive Comparison of Paxman AB's EV-to-FCF

For the Medical Devices subindustry, Paxman AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paxman AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Paxman AB's EV-to-FCF falls into.



Paxman AB EV-to-FCF Calculation

Paxman AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=62.748/1.362
=46.07

Paxman AB's current Enterprise Value is €62.75 Mil.
Paxman AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paxman AB  (FRA:B0F) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Paxman AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.20/0.037
=86.49

Paxman AB's share price for today is €3.20.
Paxman AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.037.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Paxman AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Paxman AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Paxman AB (FRA:B0F) Business Description

Traded in Other Exchanges
Address
Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB (FRA:B0F) Headlines

No Headlines